Complex movement behaviour and progression of Huntington's disease

Related Experiment Video

Updated: Jul 16, 2026

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

Jürgen Andrich1, Carsten Saft, Natalie Ostholt

  • 1Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Gudrunstrasse 56, 44791 Bochum, Germany.

Neuroscience Letters
|February 27, 2007
PubMed

Insights

Instrumental peg insertion tests show worsening motor and cognitive function in Huntington

Area of Science:

  • Neuroscience
  • Neurology
  • Movement Disorders

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Instrumental measurement of complex motor sequences, like peg insertion, can detect functional impairments.

Purpose of the Study:

  • To evaluate the 3-year progression of Huntington's disease symptoms using instrumental peg insertion tests.
  • To correlate peg insertion outcomes with clinical assessments (UHDRS) and cognitive function.

Main Methods:

  • 39 untreated Huntington's disease patients underwent assessments at baseline and after 3 years.
  • Evaluated Unified Huntington's Disease Rating Scale (UHDRS) scores, motor function, and peg insertion task performance.
  • Cognitive function was assessed and correlated with motor and clinical outcomes.

Main Results:

  • Significant worsening of UHDRS scores, bradykinesia, chorea, dystonia, and oculomotor symptoms over 3 years.
  • Motor test outcomes, including peg insertion, significantly declined.
  • Peg insertion performance correlated with cognitive function and UHDRS ratings, indicating motor and higher cognitive deficits.

Conclusions:

  • Instrumental peg insertion is a valuable tool for monitoring Huntington's disease progression, reflecting both motor and cognitive decline.
  • This method complements clinical ratings in assessing functional impairment in HD patients.
  • The findings suggest frontostriatal dysfunction underlies the observed motor and cognitive deficits in HD.

More Related Videos

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy05:54

A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy

Published on: December 29, 2017

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...